World Health Organization Strategic Advisory Group of Experts (SAGE) Interim Recommendation Supports Use of Johnson & Johnson COVID-19 Vaccine as a Booster
Growing body of evidence supports use of the Johnson& Johnson COVID-19 vaccine as both a mix-and-match and homologous booster, following primary vaccination regimen
NEW BRUNSWICK, N.J., December 9, 2021– Johnson& Johnson...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials
More News: Clinical Trials | COVID-19 | International Medicine & Public Health | Pharmaceuticals | Vaccines | WHO